Gainers
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares climbed 137.4% to close at $6.03 on Monday on abnormally-high volume. The stock is seeing increased interest by traders on social media. Also, the company filed a mixed shelf offering on Friday after the close.
The month of November shows a continued slowdown in SPAC merger deal votes, but the calendar includes several multibillion-dollar deals.
SPAC merger votes can act as a catalyst, as the votes complete the last step in the merger process and change the company over to a new name and ticker that can help build recognition.